What is the appropriate acyclovir dosing regimen for children with HSV or varicella‑zoster infections, including oral and intravenous routes and renal‑function adjustments?

Acyclovir Dosing in Children

For HSV infections in children, use acyclovir 20 mg/kg IV every 8 hours for neonatal CNS/disseminated disease (21 days) or 10 mg/kg IV every 8 hours for non-neonatal CNS disease (21 days); for mucocutaneous HSV, use 20 mg/kg oral (max 400 mg) three times daily for 5-10 days in children <45 kg. 1

HSV Infections - Intravenous Dosing

Neonatal HSV (Birth to 1 Month)

• CNS or disseminated disease: 20 mg/kg IV every 8 hours for 21 days 1
• Skin, eye, or mouth disease: 20 mg/kg IV every 8 hours for 14 days 1
• Critical monitoring: Repeat CSF HSV DNA PCR at days 19-21 of therapy; do not discontinue acyclovir until CSF PCR is negative 1

The neonatal dosing is higher than older children due to immature renal function and altered pharmacokinetics, with elimination half-life ranging from 10-15 hours in the first month of life, decreasing to 2.5 hours thereafter 2. Recent pharmacokinetic modeling confirms that preterm neonates require careful dose adjustment based on post-menstrual age and creatinine clearance 3.

Non-Neonatal Children (>1 Month)

• CNS or disseminated disease: 10 mg/kg IV every 8 hours for 21 days 1
  • Alternative dosing: 500 mg/m² IV every 8 hours 1
• Moderate to severe gingivostomatitis: 5-10 mg/kg IV every 8 hours until lesions regress, then switch to oral 1

For HSV encephalitis specifically, British guidelines recommend 14-21 days of IV acyclovir, with children aged 3 months to 12 years receiving a minimum of 21 days due to higher relapse rates (up to 29%) 1.

HSV Infections - Oral Dosing

Mucocutaneous HSV

• Children <45 kg: 20 mg/kg oral (max 400 mg/dose) three times daily for 5-14 days 1
• Mild gingivostomatitis: 20 mg/kg oral (max 400 mg/dose) three times daily for 5-10 days 1
• Genital herpes (children <45 kg): 20 mg/kg oral (max 400 mg/dose) three times daily for 5-14 days 1

The oral bioavailability in young children is approximately 12%, which is lower than adults, necessitating weight-based dosing adjustments 2.

Varicella-Zoster Infections

Chickenpox (Oral)

• Children ≥2 years and <40 kg: 20 mg/kg oral four times daily (80 mg/kg/day) for 5 days 4
• Children >40 kg and adults: 800 mg oral four times daily for 5 days 4
• Initiate within 24 hours of symptom onset for optimal efficacy 4

Severe VZV or Immunocompromised Patients

• Intravenous acyclovir is indicated for varicella-zoster infections in immunocompromised patients 4
• Dosing follows similar weight-based calculations as HSV, though specific VZV IV dosing in children may require higher doses due to the higher IC50 for VZV (1.125 mg/L vs 0.56 mg/L for HSV) 5

Renal Function Adjustments

Acyclovir is primarily renally excreted (62-91% unchanged), requiring dose modification in renal impairment. 6

Pediatric Renal Dosing Considerations

• Normal renal function (eGFR ≤250 mL/min/1.73m²): 10 mg/kg IV every 6 hours 5
• Augmented renal clearance (eGFR >250 mL/min/1.73m²): 15-20 mg/kg IV every 6 hours 5
• Renal impairment: Adjust based on creatinine clearance using standard nomograms 4, 6

Clearance is significantly affected by estimated glomerular filtration rate, body surface area, and post-menstrual age in neonates 3, 2. Children with systemic HSV infection have nearly 3-fold higher volume of distribution, requiring careful monitoring 3.

Hemodialysis

• Administer supplemental dose after each dialysis session (plasma half-life during hemodialysis is approximately 5 hours with 60% decrease in concentrations) 4

Critical Safety Considerations

Nephrotoxicity Prevention

• Administer IV acyclovir over at least 1 hour to reduce renal tubular damage risk 6
• Maintain adequate hydration throughout therapy 1
• Monitor renal function regularly; reversible nephropathy can occur in up to 20% of patients, typically after 4 days of IV therapy 1
• Neutropenia occurs in up to 46% of neonates on long-term oral suppressive therapy, though usually self-limited 1

High-Dose Considerations

For children aged 3 months to 12 years with encephalitis, high-dose acyclovir (60 mg/kg/day divided every 8 hours) shows similar renal injury rates compared to standard dosing (10.3% vs 3.1%, p=0.34), though this was not statistically significant 7. The American Academy of Pediatrics updated recommendations in 2006 to support higher dosing in this age group 7.

Acyclovir-Resistant HSV

• Foscarnet: 40 mg/kg IV every 8 hours or 60 mg/kg IV every 12 hours 1
• Administer slowly over 2 hours with saline fluid loading to minimize renal toxicity 1
• Adjust doses in renal insufficiency 1

Alternative Agents (Limited Pediatric Data)

• Valacyclovir: Approved for adults/adolescents at 1 g oral twice daily; no pediatric preparation exists, limited dosing data in children 1
• Famciclovir: Approved for adults at 500 mg oral twice daily; no pediatric preparation, limited pediatric data 1